2024 Early Hearing Detection & Intervention Conference
March 17-19, 2024 • Denver, CO
| A Quality Improvement Project to Ensure Timely Cytomegalovirus Testing and Follow Up for Babies that Do Not Pass Newborn Hearing Screening at Mayo Clinic
A Quality Improvement Project to Ensure Timely Cytomegalovirus Testing and Follow Up for Babies that Do Not Pass Newborn Hearing Screening at Mayo Clinic
Twenty-six percent of babies diagnosed as deaf or hard of hearing show evidence of cytomegalovirus (CMV) infection. CMV is a virus that infects people of all ages. Most people show no symptoms of having been infected. CMV can pose serious health problems to a baby if the mother is infected while pregnant. Some of the consequences of congenital CMV may have long term health problems. Minnesota, like most states, does not have established clinical practices to have CMV testing performed on babies who do not pass their initial newborn hearing screening. Mayo Clinic and Mayo Clinic Health System are developing practice guidelines to identify and monitor babies who have CMV in the well child population. By 21 days of age, all babies will complete CMV testing by urine or saliva using polymerase chain reaction (PCR) testing if they do not pass the second (in hospital) newborn hearing screen. If a specimen cannot be collected before discharge, primary care will be notified to accomplish this. The aim of this project is to develop a prospective protocol that includes all babies who do not pass newborn hearing screening and are CMV positive. These babies will go on to audiometric diagnostic evaluation and be referred to infectious disease specialists. All babies, regardless of their hearing status, will have regular audiometric follow up. As part of this project we will develop electronic medical record standards and clinical practice guidelines. Completion of this project will enhance early identification and management of babies who are deaf or hard of hearing as a result of CMV infection.
- To develop a quality improvement strategy where all babies who do not pass hearing screening get CMV testing by 21 days of age
- To develop a follow up plan for all babies who test positive for CMV
- To create an electronic means of tracking these babies and to create a family centered educational tool
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
3478265_17880MCHBHRSA.rtf
Presenters/Authors
Lee Belf
(Primary Presenter,Author), Mayo Clinic Rochester, belf.lee@mayo.edu;
Lee received her B.A. and M.A. degrees at Western Michigan University. She received her Au.D. from University of Florida. Lee has been an audiologist at Mayo Clinic Rochester, MN since 1990 with her primary interest in Pediatric Audiology.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Joscelyn Martin
(Author), Mayo Clinic Rochester, martin.joscelyn@mayo.edu;
Joscelyn R.K. Martin, Au.D. is a pediatric audiologist at the Mayo Clinic in Rochester, Minnesota. She holds Pediatric Audiology Specialty Certification (PASC) from the American Board of Audiology. Dr. Martin has been coordinator of the Mayo Clinic Early Hearing Detection and Intervention (EHDI) program since its inception in 1999. In addition to early intervention for children with hearing loss, she is passionate about child and family centered counseling and the positive impact it has on the diagnostic and re/habilitative process for the families with whom she works.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Charles Huskins
(Author), Mayo Clinic Rochester, huskins.charles@mayo.edu;
Dr. Huskins' research is focused on improving health care by studying interventions to prevent health-care-associated infections and to improve use of antimicrobial agents, which can lead to infections caused by antimicrobial-resistant bacteria.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Lisa Schimmenti
(Author), Mayo Clinic Rochester, schimmenti.lisa@mayo.edu;
Dr. Schimmenti is a Senior Associate Consultant at Mayo Clinic in the departments of Otorhinolaryngology, Clinical Genomics and Biochemistry and Molecular Biology. She is the AAP Chapter Champion for Minnesota and the regional champion for Region VI. She has served on the Minnesota Department of Health Newborn Hearing Screening Committee for over a decade. Her basic science laboratory studies hearing and vision in zebrafish.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Gayla L. Poling
(Author), Mayo Clinic, Rochester, MN, poling.gayla@mayo.edu;
Gayla L. Poling, Ph.D. is the Director of Diagnostic Audiology Research at Mayo Clinic, Rochester, MN. She is an Assistant Professor of Audiology, Mayo Clinic College of Medicine. She studied Audiology and Hearing Sciences at The Ohio State University and completed postdoctoral fellowships at the Medical University of South Carolina and Northwestern University. Her primary interest is auditory diagnostics with her research focused on early detection and prevention of hearing loss across the life course.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -